D'Incalci M - Search Results

1

Pharmacokinetics of 4-demethoxydaunorubicin in cancer patients.

Zanette L, Zucchetti M, Freshi A, Erranti D, Tirelli U, D'Incalci M. Zanette L, et al. Cancer Chemother Pharmacol. 1990;25(6):445-8. doi: 10.1007/BF00686057. Cancer Chemother Pharmacol. 1990. PMID: 2311174

2

Activity of aphidicolin glycinate alone or in combination with cisplatin in a murine ovarian tumor resistant to cisplatin.

Damia G, Tagliabue G, Zucchetti M, Davoli E, Sessa C, Cavalli F, D'Incalci M. Damia G, et al. Cancer Chemother Pharmacol. 1992;30(6):459-64. doi: 10.1007/BF00685597. Cancer Chemother Pharmacol. 1992. PMID: 1394802

3

O6-Alkylguanine-DNA alkyltransferase content in synchronised human cancer cells.

Coccia P, Sen S, Erba E, Pagani P, Marinello C, D'Incalci M. Coccia P, et al. Cancer Chemother Pharmacol. 1992;30(1):77-80. doi: 10.1007/BF00686490. Cancer Chemother Pharmacol. 1992. PMID: 1586985

4

Do anticancer agents reach the tumor target in the human brain?

Donelli MG, Zucchetti M, D'Incalci M. Donelli MG, et al. Cancer Chemother Pharmacol. 1992;30(4):251-60. doi: 10.1007/BF00686291. Cancer Chemother Pharmacol. 1992. PMID: 1643692 Review.

5

Phase I and clinical pharmacological evaluation of aphidicolin glycinate.

Sessa C, Zucchetti M, Davoli E, Califano R, Cavalli F, Frustaci S, Gumbrell L, Sulkes A, Winograd B, D'Incalci M. Sessa C, et al. J Natl Cancer Inst. 1991 Aug 21;83(16):1160-4. doi: 10.1093/jnci/83.16.1160. J Natl Cancer Inst. 1991. PMID: 1886148 Clinical Trial.

6

Concentrations of VP16 and VM26 in human brain tumors.

Zucchetti M, Rossi C, Knerich R, Donelli MG, Butti G, Silvani V, Gaetani P, D'Incalci M. Zucchetti M, et al. Ann Oncol. 1991 Jan;2(1):63-6. doi: 10.1093/oxfordjournals.annonc.a057826. Ann Oncol. 1991. PMID: 2009235 Free article.

7

Cytotoxicity and DNA damage caused by 4-demethoxydaunorubicin and its metabolite 4-demethoxy-13-hydroxydaunorubicin in human acute myeloid leukemia cells.

Limonta M, Biondi A, Giudici G, Specchia G, Catapano C, Masera G, Barbui T, D'Incalci M. Limonta M, et al. Cancer Chemother Pharmacol. 1990;26(5):340-2. doi: 10.1007/BF02897289. Cancer Chemother Pharmacol. 1990. PMID: 2208574

8

Pharmacokinetics of intrapleural versus intravenous etoposide (VP 16) and teniposide (VM 26) in patients with malignant pleural effusion.

Montaldo PG, Figoli F, Zanette ML, Sorio R, Zucchetti M, Tirelli U, D'Incalci M. Montaldo PG, et al. Oncology. 1990;47(1):55-61. doi: 10.1159/000226785. Oncology. 1990. PMID: 2300386

9

DNA damage and cytotoxicity of mitoxantrone and doxorubicin in doxorubicin-sensitive and -resistant human colon carcinoma cells.

Capolongo L, Belvedere G, D'Incalci M. Capolongo L, et al. Cancer Chemother Pharmacol. 1990;25(6):430-4. doi: 10.1007/BF00686054. Cancer Chemother Pharmacol. 1990. PMID: 2311171

10

Flavone acetic acid distribution in human malignant tumors.

Damia G, Freschi A, Sorio R, Braida A, Caruso G, Quaia M, Monfardini S, D'Incalci M. Damia G, et al. Cancer Chemother Pharmacol. 1990;26(1):67-70. doi: 10.1007/BF02940298. Cancer Chemother Pharmacol. 1990. PMID: 2322990

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

563 results

Search Page

Filters